Chlorhexidine Gluconate Wipes Market size was over USD 314.7 million in 2024 and is estimated to reach USD 558.7 million by the end of 2037, expanding at a CAGR of 4.9% during the forecast timeline, i.e., 2025-2037. In 2025, the industry size of chlorhexidine gluconate wipes is assessed at USD 330.1 million.
The rising popularity of disinfectants and antiseptics for both hospital and residential use is driving growth in the chlorhexidine gluconate (CHG) wipes market. The general availability of these products has majorly propelled sales in this industry. According to 2022 OEC data, the global trade of packaged disinfectants in retail sales reached USD 3.4 billion, with top exporters being China, Germany, the U.S., the UK, and Belgium. Particularly, the increased awareness about maintaining hygiene after the pandemic strike has significantly increased purchases in this field.
As per a study conducted by NLM, in December 2020, household disinfectant wipes usage per week was noticed to increase by 138% during the COVID-19 pandemic. Infection prevention practices are further stimulated by accelerated regulatory approvals and recommendations. This is attracting more pharmaceutical manufacturers to introduce new product pipelines, diversifying the chlorhexidine gluconate wipes market. Many are also unveiling extended applications of these disinfectants in veterinary care, expanding the market reach.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.9% |
|
Base Year Market Size (2024) |
USD 314.7 million |
|
Forecast Year Market Size (2037) |
USD 558.7 million |
|
Regional Scope |
|
Concentration (2%, 5%)
In terms of concentration, the 5% segment is projected to dominate chlorhexidine gluconate wipes market share of over 69.9% by 2037. The varied applications in the healthcare industry have made this segment one of the most preferable cleaning products. Their efficacy in skin antisepsis, infection prevention, and hygiene control is increasing the popularity of this concentration. It helps to kill a broad range of bacteria, viruses, and fungi, which attracts surgical centers to implement 5% CHG wipes in their medical procedures. Considering its efficiency and pivotal role in clinical and surgical disinfection, WHO placed the chlorhexidine digluconate 5% solution in its 2023 list of essential medicines.
Product Type (CHG Bath Wipes, CHG/Alcohol-Based Wipes)
Based on product type, the CHG bath wipes are estimated to captivate a significant share of the chlorhexidine gluconate wipes market by the end of 2037. The growth in this segment is majorly driven by the increasing demand for critical patient care. Specifically, the aging global population is creating a demanding consumer base for these personnel hygiene products. In 2020, NLM released an estimation of the total number of elderly in different health states in Thailand. The study projected the country to contain 153,640 bedridden patients by 2030. Similar countries such as Japan, China, and the U.S. have some of the oldest populations, making the CHG bath cleansers essential to maintain their health.
Our in-depth analysis of the global market includes the following segments:
|
Concentration |
|
|
Product Type |
|
|
Application |
|
|
Distribution Channel |
|
North America Market Analysis
North America chlorhexidine gluconate wipes market is predicted to capture revenue share of over 35.6% by 2037. The region is well-equipped with a strong healthcare infrastructure, which helps in sufficient medical product distribution, creating a profitable environment for this sector. In addition, the economic growth of this region has remarkably contributed to the increased healthcare expenditure, profiting this sector. According to the National Health Expenditure Account (NHEA), U.S. healthcare expenses increased by 7.5% in 2023, holding a value of USD 4.9 trillion, capturing 17.6% of the nation’s GDP.
Considering the rising incidences of healthcare-associated infection (HAI), the U.S. chlorhexidine gluconate (CHG) wipes market is growing notably. The country is garnering in-house forces to cope with the rising demand for such effective disinfectants to control the outrage. On that note, in May 2021, Mediline announced its acquisition of 40% domestic market share through the success of its ReadyPrep CHG cloths, launched in 2019. The pre-op skin antiseptic solution rolled out across the country, which inspired the company to invest USD 10 million to boost the manufacturing capacity, R&D, and clinical trials.
Canada is proactively empowering the regional chlorhexidine gluconate wipes market by investing heavily to prevent HAI spread in its healthcare settings. The country’s efforts are directly contributing to the development of this sector, as the financial support enhances new product discoveries and optimum adoption. For instance, in August 2021, Infection Prevention and Control Canada released a federal budget, highlighting the funding of USD 3 billion over five years to accommodate adequate healthcare settings. The investment directly targeted the development of long-term patient facilities to fight against infectious outbreaks.
APAC Market Statistics
The Asia Pacific chlorhexidine gluconate wipes market is projected to witness the fastest growth during the forecast period. The combined efforts from both private and government institutions to promote the use of disinfectants have increased the popularity of CHG-based wipes in this region. Manufacturing powerhouses such as China and India are deliberately forcing healthcare facilities to adopt such effective cleaning and sterilizing products by securing a sufficient domestic supply.
India is strengthening the production and distribution channels of its domestic market by empowering local participants. With a strong emphasis on the pharma industry, the country is cultivating promising CHG solutions for healthcare disinfection. India is promoting the use of disinfectants. According to an NLM report, published in May 2022, the Infection Prevention and Control (IPC) program in India trained 2552 HCPs and 548 medical students to penetrate cleaning practices in healthcare. The program showcased a 30% increment in surface disinfection and cleaning through repeated training.
China is utilizing its manufacturing strength to make progress in the chlorhexidine gluconate wipes market. It is creating a well-established marketplace for both domestic and international leaders by using increased demand and enhanced production across the country. According to the 2022 OEC data, China secured its position among the top exporters of packaged disinfectants. It achieved USD 510 million export value of such products for retail sale to emerging landscapes such as the U.S., Germany, France, and Canada.
The market is experiencing steady growth due to the active participation of the key players. They are introducing more effective CHG-based products to suit healthcare disinfection needs. Many are now putting efforts into accelerated approvals from regulatory frameworks such as the FDA to streamline and expand their product line. For instance, in 2020, Stryker launched Sage 2% chlorhexidine gluconate cloths with a 40% additional concentrated dose to prevent SSIs effectively. The FDA-approved CHG wipes are clinically validated to deliver excellence in disinfection. Such key players include:
Author Credits: Radhika Pawar
Copyright © 2025 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?